chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Dizziness; Fatigue; got the injection his left arm was a little sore/Severe left arm pain, soreness, throbbing; intermittent kind of dyslexia; This is a spontaneous report from a contactable consumer (respiratory therapist - patient himself).  A 52-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot/batch number EK5730) via an unspecified route of administration on the left arm on 17Dec2020 at SINGLE DOSE for COVID-19 immunization (also reported as vaccination).  Ongoing medical history included type 2 diabetes mellitus since Dec2003, renal disorder (reported as kidney prevention) and blood cholesterol abnormal (cholesterol was not high, but because of Type II Diabetes his doctor wanted to keep it at bay). Ongoing concomitant medications included metformin (METFORMIN) since Jan2004 for type II Diabetes, lisinopril (LISINOPRIL) since May2020 for kidney prevention and atorvastatin (ATORVASTATIN) since May2020 for cholesterol. On 17Dec2020, the patient had first dose administered of BNT162B2. When he got the injection, his left arm was a little sore (like if he leaned against his left arm or rubbed it he would notice the soreness). About mid-morning on 20Dec2020, his left arm just started throbbing like he had just blocked a lacrosse ball shot, severe left arm pain, and soreness. He also had onset of dizziness and fatigue as well on 20Dec2020. He went on, did a heating pad and ibuprofen and all that stuff and all that went on. He found it odd because these events did not start until around like 3 days after the injection was administered though the paperwork showed that these kind of events are expected in the first couple of days after product administered. On 21Dec2020 when he woke up around 11:30am, the throbbing went away, he was not as dizzy as before but still super fatigued and tired (then further stated that maybe a little bit better because he does not have that constant pain constantly draining him). The patient also mentioned that he wondered if there was an intermittent kind of dyslexia that he has because he will transpose words and just last week learned how to spell received without having to tell himself 'i before e except after c'. He also mentioned that he was tested like 4 times for COVID-19 and was negative every time in 2020. The outcome of the event of dyslexia was unknown while recovering for the remaining events.
Baby found dead in crib less than 24 hours after vaccine administered. Had minimal temp to 100F prior to being put down to bed at 2 AM was found dead at 8 am.  08/21/07 Received autopsy report which states COD as SIDS & co-sleeping w/parents.  Tox screen neg except for therapeutic amount of acetaminophen.
Bruise and redness (circular pattern) at site of injection. Pt works in MD office -- MD prescribed 5 days of antibiotics.
ADMINISTRATION OF VACCINE FOR MORE THAN 6 HOURS AFTER THE FIRST VIAL PUNCTURE (VIALS STORED IN THE FRIDGE AFTER PUNCTURE) (OUT OF SPECIFICATION PRODUCT USE); INCORRECT PRODUCT STORAGE; This spontaneous report received from a health care professional concerned multiple patients. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patients received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 204B21A, expiry: UNKNOWN) dose, start therapy date were not reported for prophylactic vaccination. No concomitant medications were reported.  On an unspecified date, the patient experienced administration of vaccine for more than 6 hours after the first vial puncture (vials stored in the fridge after puncture) (out of specification product use), and incorrect product storage. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the administration of vaccine for more than 6 hours after the first vial puncture (vials stored in the fridge after puncture) (out of specification product use) and incorrect product storage was not reported. This report was non-serious. This case, from the same reporter is linked to 20220528115, 20220528178, 20220528223 and 20220528196.
Information has been received concerning a 39 year old patient who on 12/02/2004 was vaccinated with a dose of varicella virus vaccine live.  On 12/18/2004 the patient developed a breakthrough case of chickenpox.  Unspecified medical attention was sought.  There was no product quality complaint.  The reporter also indicated that another patient developed an adverse event.  Additional information has been requested.
11Mar91 pt recvd DTP/OPV/MMR/HIB vaxs,on 13Mar91 mom returned for PPD reading &stated pt began running T of 103 approx 3 hrs /p vax &/w some relief /w APAP-last noc could not get T down-started having sz &muscle twitching-took to ER.
Patient was given an undiluted vial of the Pfizer Covid 6-59m 2023-2024 vaccine. Reported to Pfizer. Family was made aware. No side effects noted on the day the vaccine was given. Advised parents to call back with concerning symptoms.
patient get the flu; Initial information regarding an unsolicited valid non-serious social media case was received from a non-healthcare professional (consumer) on 08-Dec-2020.  This case involves adult patient who experienced patient get the flu (Influenza), while patient received vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), concomitant medication(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via unknown route in unknown administration site.  On unknown date, (unknow latency) The patient developed a non-serious patient get the flu (influenza) (unknown latency) following the administration of INFLUENZA VACCINE.  No relevant laboratory details were provided.  It was not reported if the patient received a corrective treatment.  The event outcome was reported as unknown.  There will be no information available on the batch number for this case.
Expired vaccine used; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 51-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Nov-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 ml. On 18-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 18-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications reported. No treatment medications reported.   The patient was administered the vaccine beyond the expired date. The vials remained frozen until the date of use and were thawed in the vaccine refrigerator prior to use.
Started with aching arm followed by shaking chills, fever, body aches, headache, nausea, and lasted about 24 hours.
increased urinary frequency; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A male patient received bnt162b2 (BNT162B2), administration date 09Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Benign Prostatic Hyperplasia", start date: Sep2020 (unspecified if ongoing); "Green Light Laser surgery" (unspecified if ongoing), notes: on my prostate.; "Non-Hodgkins B-cell Follicular Lymphoma Grades 1-2", start date: Aug2017 (unspecified if ongoing), notes: Diagnosed with Non-Hodgkins B-Cell Follicular Lymphoma Grades 1-2 in August 2017.; "Lymphoma has been in remission", start date: Feb2018 (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Treanda for Chemo, notes: I had 6 months of chemo with Rituxin and Treanda. The following information was reported: POLLAKIURIA (non-serious) with onset 09Mar2021, outcome "unknown", described as "increased urinary frequency". The event "increased urinary frequency" was evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Right arem very swollen, red and hot to touch. So swollen ithe bandage left an indentation and a blister came.
swelling of injection site very sore arm after administration  giant welt appeared on right arm less than 24 hours after administration  only went away after taking Benadryl for2-3 days
possible oculo-respiratory syndrome. The symptoms include red eyes, cough, wheezing, and chest tightness.
Pfizer vaccine was not removed from the freezer at the 14 day cutoff when it is supposed to be moved to warmer fridge temperature. This vaccine was kept in the freezer and thawed at the 19 day mark. The vaccine does not have stability data published after 17 days, but was not yet expired or out of freezer at any time other than to thaw.
Patient developed a rash on the right hand and on her Legs two days after getting vaccination. She got the vaccine to her left hand.
shingles; other zoster related injuries; Initial information has been received from a lawyer concerning a case in litigation and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapy were not repoted. On or abotu 01-JUL-2017, the patient was vaccinated with za dose of oster vaccine live (ZOSTAVAX) (dose, route of administration, lot # and expiration date were not reported) by healthcare provider for the long-term prevention of shingles and zoster-related conditions. Subsequently patient  was treated by a healthcare provider and nurse practitioner for the following injuries resulting from the patient's dose of oster vaccine live (ZOSTAVAX) use: shingles and other zoster related injuries. The outcome of the events was not reported. The reporter considered shingles and other zoster related injuries to be related to dose of oster vaccine live (ZOSTAVAX).
Patient came in on 5/5/21 to receive 2nd dose of vaccine. Her CDC card states that she received Pfizer, but she thought it was Moderna on 4/14/21. She received a dose of Moderna.  I have recommended she reach out to her  PCP to determine if she should receive another dose of Pfizer.
General soreness; Itchiness in arm; headache came on within hours, and was made far worse by exposure to bright light\sunlight.; This is a spontaneous report from a contactable consumer (patient). A 48-years-old non pregnant female patient reported for herself that she received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EUO177), via an unspecified route, administered in arm left on 16May2021 at 09:45 AM (age at vaccination was 48 years) as dose 2, single for covid-19 immunization at pharmacy or drug store. The patient was not pregnant at the time of vaccination. No other vaccines were received within four weeks prior to the administration of bnt162b2. Medical history included hashimoto, obesity and known allergy to trees, cats, dogs, ragweed; all from an unknown date and unknown if ongoing. Concomitant medications included levothyroxine sodium (SYNTHROID), phentermine (ADIPEX [PHENTERMINE]), metformin, hydrochlorothiazide (HYDRODIURIL), multivitamin; all taken in two weeks for an unspecified indication, start and stop date were not reported. The patient previously received bnt162b2 (Batch/Lot Number: EUO170), via an unspecified route, administered in arm left on 25Apr2021 (age at vaccination was 48 years) as dose 1, single for covid-19 immunization and experienced mild sore arm, mild headache. On 16May2021 at 01:15 PM, after the second injection, the patient's headache came on within hours and was made worse by exposure to bright light\sunlight. Staying in the dark was more effective than OTC unspecified pain medications. On 18May2021, the next 2 days, the patient experienced general soreness\itchiness in arm. No treatment was received for the events. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was not tested for COVID-19. Outcome of all events was recovered on an unspecified date in 2021.  Follow-up attempts are completed. No further information is expected.
On 12-14-15 patient was given both MMRV and Varicella. Patient was treated 10 days prior to this for positive strep. Parent reported rash on 12-24-15, was seen by provider and recommended BENADRYL PRN. As of 12-29-15 rash was gone, no other symptoms reported.
Presented with acute hyperkalemia related to dehydration and poor intake nephro consulted hyperkalemia treated.    Incidental finding of COVID-19 infection and asymptomatic
swollen lymph nodes; feeling of fullness in ears; This is a spontaneous report from a contactable nurse (patient). A 26-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number EH9899 and expiry date unknown) intramuscular at the right arm on 21Dec2020 14:30 at single dose for Covid-19 immunization in a hospital. The patient's medical history was not reported. The patient has no COVID prior vaccination. Concomitant medication included paracetamol (TYLENOL), ibuprofen, famotidine (PEPCID [FAMOTIDINE]) and ethinylestradiol, norgestimate (TRI FEMYNOR); all from unspecified date for unspecified indication. The patient has no other vaccine in four weeks. On 21Dec2020 15:45, the patient experienced swollen lymph nodes and feeling of fullness in ears. The patient was not COVID tested post vaccination. The patient did not received treatment for the events. The outcome of the events swollen lymph nodes and feeling of fullness in ears was recovering. The reporter considered the event non-serious; which did not result in death, not life threatening, did not cause/prolong hospitalization, not disabling/incapacitating and no congenital anomaly/birth defect.
This case was reported in a literature article and described the occurrence of peripheral neuropathy in a 58-year-old female subject who was vaccinated with LYMERIX (GlaxoSmithKline), Hepatitis A vaccine. The subject was previously healthy. On an unspecified date, the subject received 1st dose of LYMERIX (unknown route, unknown injection site), unspecified dose of Hepatitis A vaccine (unknown route, unknown injection site). Lot numbers were not provided. Within days of vaccination with Hepatitis A vaccine and LYMERIX, the subject developed headaches, stiff neck, and dry mouth. In subsequent weeks, she experienced diarrhea alternating with constipation, atrial fibrillation, leg edema, memory loss, and poor concentration in addition to the neuropathy symptoms (paresthesia of hands and feet, mild vibratory loss in feet and pinprick sensation decreased in toes and hands). The symptoms fluctuated and persisted at the time of presentation, which was two months to six years after symptom onset. Nerve conduction studies were within normal limits. Skin biopsy studies revealed decreased epidermal nerve fiber (ENF) densities in the calf. Calf: 2, 3; Thigh: normal. This case was assessed as medically serious by GSK. At the time of reporting the outcome of the events was unspecified.
Asthma/COPD exacerbation with swab positive for Rhinovirus. ED visit and hospital admission. This visit was within 6 weeks of receiving the COVID vaccine.
major back pain, very tired,  very sore arm, left hip pain,  chills, sweats, low grade temp that would not go away with meds, headache
Low grade fever - 12 hours Unbalanced - 6 hours Fatigue - 24 hours Disoriented - 6 hours Resolved with bedrest  Recovery within 24 hours
Numbness in feet, feeling in hands intermittent, migraine headaches, knee giving out, and other neurological issues.
Case number PHEH2016US027049, is an initial spontaneous report received from a nurse on 17 Oct 2016. This report refers to a 59 years old female patient. Medical history and concomitant medications were not reported. The patient was vaccinated with a single dose of FLUCELVAX QUADRIVALENT (batch number: 185888) at a dose of 0.5 ml intramuscularly on 17 Oct 2016. The nurse reported that, temperature excursion occurred with FLUCELVAX pre filled syringes (PFS) in an closed refrigerator. The vaccines were cool when touched. The nurse estimated, the time of excursion was 2 to 3 days. The maximum temperature was estimated to be less than  77 degrees F. That was the first temperature excursion. The vaccine was administered to 7 people. No adverse event was reported following this administration error.
In June or July I was hospitalized and during treatment they ran a CT test and discovered a pulmonary embolism.  I was told later that its chronic later by my PCP and that I also have Pericarditis or Myocarditis by my insurance but hadn't been told by the doctor. I am told I have to take Eliquis for 6 months to a year or that I have chronic blood clots. I have not been treated for the Pericarditis as no one told me other than the nurse who was reading my healthcare records to me over the phone through my insurance. I cannot 100 percent verify that my adverse conditions were caused by the Pfizer vaccine. I got the Pfizer vaccine in March, April, and September of 2021. They dont know the cause of my conditions. I did not have them prior to June when I got the CT scan or to 2021. I did have sleep apnea diagnosed. My health is getting worse and worse. I have dizzy spells, heart palpitations. I can not work or do anything physical. Because I can't do anything physical much already, I have a muscle and neuropathy condition. I wonder if CMT or Charcot Marie tooth caused the interaction or adverse reaction. CMT is a disease its Genetic it causes duplication of the PMP22 Gene that makes your myeline or the outer layer of tissue in your nerves and muscles wear thin or degenerate over time and its diagnosed at birth. Its an illness that is hereditary. If this illness is related to the adverse reaction it might prevent someone else from this rare side effect from getting blood clots and heart defects from a vaccine. Im only trying to help transparency. I hoped the vaccine was safe, but I did run blood tests before getting the Pfizer vaccine and was perfectly healthy other than mild low in vitamin D. Now Im low in Iron vitamin B D and white blood cell count as well. So I worry that my immunity has waned as well. Some clarity would help, but i cant find any clarity without research or understanding. I was pressured to get the vaccine and now I am worried I made a mistake.
Headache started in the afternoon yesterday and got progressed; I took Tylenol but it is not going away; Muscle pain; Chills; Joint pain; Fever; Nausea; Injection site pain; Tiredness; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 39-year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 10Sep2021 09:00 (Lot number: FC3184) at the age of 39 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Depression" (unspecified if ongoing), notes: Verbatim: Depression; "Anxiety" (unspecified if ongoing), notes: Verbatim: Anxiety; "Chronic pain" (unspecified if ongoing), notes: Verbatim: Chronic pain. The patient's concomitant medications were not reported. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 2021, outcome "unknown", described as "Injection site pain"; FATIGUE (non-serious) with onset 2021, outcome "unknown", described as "Tiredness"; HEADACHE (non-serious) with onset 10Sep2021 13:00, outcome "recovering", described as "Headache started in the afternoon yesterday and got progressed; I took Tylenol but it is not going away"; MYALGIA (non-serious) with onset 2021, outcome "unknown", described as "Muscle pain"; CHILLS (non-serious) with onset 2021, outcome "unknown", described as "Chills"; ARTHRALGIA (non-serious) with onset 2021, outcome "unknown", described as "Joint pain"; PYREXIA (non-serious) with onset 2021, outcome "unknown", described as "Fever"; NAUSEA (non-serious) with onset 2021, outcome "unknown", described as "Nausea". Therapeutic measures were taken as a result of headache.  Additional information: Patient stated calling to report the side effects. Patient stated, injection pain site, tiredness, headache, muscle pain, chills, joint pain, fever and nausea having that all. The vaccine dose received Just the first dose. yesterday morning, 10Sep2021 about 9 o'clock in the morning. Patient stated, My headache started about 1 o'clock in the afternoon yesterday and It's progressed. Patient stated, I take a lot of medications. Prior vaccination, patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient had no family history related to vaccination similar adverse event. The patient stated, took some Tylenol, That's all. I am taking treatment for the events. The patient stated that still experiencing the event. The patient stated I took Tylenol but It's not going away (headache). The second dose vaccination due date was 01Oct2021.  Follow-up attempts are completed. No further information is expected.
Pain in left deltoid where shot was administered has not subsided, it's been 4 days now and I'm still having pain as thought I've been punched in the arm (really hard). I do not have full use of my arm nor full range of motion. The pain is only where the shot was administered not my entire arm, due to the pain my arm is weakened.
Already received the first dose of the Pfizer COVID-19 vaccine and came up positive to COVID-19; Already received the first dose of the Pfizer COVID-19 vaccine and came up positive to COVID-19; This is a spontaneous report from a contactable consumer (patient). A male patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number and Expiration Date were not reported), via an unspecified route of administration, on 03Apr2021, at a single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient already received the first dose of the Pfizer COVID-19 vaccine on 03Apr2021 and last week (Apr2021), he came up positive to COVID-19. The patient's appointment to get the second dose is tomorrow (23Apr2021) and he would like to know if he can go to the appointment and get the vaccine. The outcome of the events was unknown.  Information about lot number and expiration date for the suspect product will be requested in follow-up attempts.